Patients undergoing unilateral adrenalectomy for unilateral PA
This procedure leads to cure of hypertension in 50% to 60% of carefully selected patients and improvement in all of the remainder.[27]Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):33-9.
http://www.ncbi.nlm.nih.gov/pubmed/15134798?tool=bestpractice.com
[107]Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003 Nov;21(11):2149-57.
http://www.ncbi.nlm.nih.gov/pubmed/14597859?tool=bestpractice.com
[115]Celen O, O'Brien MJ, Melby JC, et al. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996 Jun;131(6):646-50.
http://www.ncbi.nlm.nih.gov/pubmed/8645073?tool=bestpractice.com
[116]Rutherford JC, Taylor WL, Stowasser M, et al. Success of surgery in primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998 Dec;22(12):1243-5.
http://www.ncbi.nlm.nih.gov/pubmed/9841751?tool=bestpractice.com
[117]Stowasser M, Klemm SA, Tunny TJ, et al. Response to unilateral adrenalectomy for aldosterone-producing adenoma - effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol. 1994 Apr;21(4):319-22.
http://www.ncbi.nlm.nih.gov/pubmed/7923899?tool=bestpractice.com
BP typically normalizes or shows maximum improvement in 1 to 6 months after unilateral adrenalectomy, but can continue to fall for up to 1 to 2 years in some patients.[6]Stowasser M, Gordon RD, Rutherford JC, et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):156-69.
http://journals.sagepub.com/doi/pdf/10.3317/jraas.2001.022
http://www.ncbi.nlm.nih.gov/pubmed/11881117?tool=bestpractice.com
Primary aldosteronism (PA)is biochemically cured in 70% of fully worked-up patients, and improved in all remaining patients.[27]Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):33-9.
http://www.ncbi.nlm.nih.gov/pubmed/15134798?tool=bestpractice.com
[107]Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003 Nov;21(11):2149-57.
http://www.ncbi.nlm.nih.gov/pubmed/14597859?tool=bestpractice.com
[116]Rutherford JC, Taylor WL, Stowasser M, et al. Success of surgery in primary aldosteronism judged by residual autonomous aldosterone production. World J Surg. 1998 Dec;22(12):1243-5.
http://www.ncbi.nlm.nih.gov/pubmed/9841751?tool=bestpractice.com
Less than 20% of patients require equivalent or increased medication doses after surgery.[104]Yip L, Duh QY, Wachtel H, et al. American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022 Oct 1;157(10):870-7.
https://jamanetwork.com/journals/jamasurgery/fullarticle/2795363
http://www.ncbi.nlm.nih.gov/pubmed/35976622?tool=bestpractice.com
There is a consistent improvement in quality of life. Cohort studies have shown marked improvements in cardiovascular parameters (including left ventricular mass on echo).[61]Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996 May;27(5):1039-45.
http://hyper.ahajournals.org/content/27/5/1039.full
http://www.ncbi.nlm.nih.gov/pubmed/8621194?tool=bestpractice.com
[125]Catena C, Colussi GL, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007 Nov;50(5):911-8.
http://hyper.ahajournals.org/content/50/5/911.full
http://www.ncbi.nlm.nih.gov/pubmed/17893375?tool=bestpractice.com
Recurrence of PA in those apparently cured after 12 months is uncommon. In patients with persistent (albeit improved) PA, hypertension may respond well to small doses of aldosterone antagonist medications, but caution is required as the levels of aldosterone have probably been substantially reduced.[6]Stowasser M, Gordon RD, Rutherford JC, et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):156-69.
http://journals.sagepub.com/doi/pdf/10.3317/jraas.2001.022
http://www.ncbi.nlm.nih.gov/pubmed/11881117?tool=bestpractice.com
Patients undergoing treatment with aldosterone antagonist medications
Hypertension is improved and control achieved in the majority.[27]Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):33-9.
http://www.ncbi.nlm.nih.gov/pubmed/15134798?tool=bestpractice.com
[107]Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003 Nov;21(11):2149-57.
http://www.ncbi.nlm.nih.gov/pubmed/14597859?tool=bestpractice.com
[122]Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001 Mar;19(3):353-61.
http://www.ncbi.nlm.nih.gov/pubmed/11288803?tool=bestpractice.com
Hypokalemia, when present, is almost always corrected.
However, improvements aren't as dramatic as after unilateral adrenalectomy for lateralizing lesions. In cohort studies, the mean number of antihypertensive medications required did not fall as markedly, and there was less impressive improvement in echocardiographically derived left ventricular mass.[27]Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):33-9.
http://www.ncbi.nlm.nih.gov/pubmed/15134798?tool=bestpractice.com
[61]Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996 May;27(5):1039-45.
http://hyper.ahajournals.org/content/27/5/1039.full
http://www.ncbi.nlm.nih.gov/pubmed/8621194?tool=bestpractice.com
Patients with FH-I undergoing treatment with glucocorticoid medications
Hypertension in familial hyperaldosteronism type I (FH-I) is frequently of early onset and may be severe enough to cause early death, usually from hemorrhagic stroke, unless specifically treated.[20]Stowasser M, Gartside MG, Gordon RD. A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I. Aust N Z J Med. 1997 Dec;27(6):685-90.
http://www.ncbi.nlm.nih.gov/pubmed/9483237?tool=bestpractice.com
[21]Rich GM, Ulick S, Cook S, et al. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med. 1992 May 15;116(10):813-20.
http://www.ncbi.nlm.nih.gov/pubmed/1567095?tool=bestpractice.com
However, treatment with glucocorticoids, given in low doses that do not cause Cushingoid adverse effects, is usually highly effective at controlling hypertension (and thereby preventing stroke), with supplementary antihypertensives only occasionally required.[132]Walker BR, Edwards CR. Dexamethasone-suppressible hypertension. Endocrinologist. 1993 Mar;3(2):87-97.
http://journals.lww.com/theendocrinologist/Abstract/1993/03000/Dexamethasone_Suppressible_Hypertension_.3.aspx